CompanyStageLast valuationTotal raised
LLycia Therapeutics, Inc.Lycia Therapeutics develops LYTAC degraders that remove disease-causing extracellular proteins for autoimmune and inflammatory diseases.Series CHealthcareLast valuationUndisclosedTotal raisedSign inMMagnus Medical, Inc.Magnus Medical, based in Burlingame, California, develops the SAINT Neuromodulation System for adults with major depressive disorder.Series BHealthcareLast valuationUndisclosedTotal raisedSign inMMajesty Therapeutics, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$100KM
MalarVx, Inc.Won a federal SBIR/STTR research award from HHS and other federal agencies.SeedHealthcareLast valuationUndisclosedTotal raised$125KMMati Therapeutics Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$2.6MMMaxymune Therapeutics, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$2.7MMMC2 Therapeutics LimitedUK private limited company incorporated 2005.Late stageHealthcareLast valuationUndisclosedTotal raised$0MMC Diagnostics LTDUK private limited company incorporated 2006.Late stageHealthcareLast valuationUndisclosedTotal raised$0MMedical 21, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$550KMMedicenna Therapeutics Corp.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$253.5KM
MedVector CorpRaised capital from retail investors through a Regulation Crowdfunding offering on StartEngine Capital, LLC.SeedHealthcareLast valuationUndisclosedTotal raised$1MMMeiragtx UK II LimitedUK private limited company incorporated 2014.Late stageHealthcareLast valuationUndisclosedTotal raised$0MMemento Medicines, Inc.Memento Medicines, Inc., founded in 2026 in Boston, is developing MMT-205, a bispecific antibody for retinal diseases.Series BHealthcareLast valuationUndisclosedTotal raised$38MMMentat Biotechnology, Corp.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$10KMMercury Bio, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$1.6MMMereo Biopharma Group PLCUK public limited company incorporated 2015.PublicHealthcareLast valuationUndisclosedTotal raisedSign inMMetisculpt, IncPrivate securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$550KM
MicroPure Genomics, Inc.Won 3 federal SBIR/STTR research awards from NSF and other federal agencies.SeedHealthcareLast valuationUndisclosedTotal raised$675KMMina (Holdings) LimitedUK private limited company incorporated 2014.Late stageHealthcareLast valuationUndisclosedTotal raised$0MMirobio LTDUK private limited company incorporated 2018.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inMMitera Biosciences Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$1.1MMModerna Biotech UK LimitedUK private limited company incorporated 2019.Late stageHealthcareLast valuationUndisclosedTotal raised$0MMonocacy Therapeutics Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$25KMMSD R&D Innovation Centre LimitedUK private limited company incorporated 1969.Late stageHealthcareLast valuationUndisclosedTotal raised$0MMyrtelle Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$16.7M